Theorem Clinical Research

Awards & Advancement

Icon Firecrest receives global award for healthcare training animation

Thursday, November 20, 2014 12:50 PM

Icon Firecrest, a provider of integrated Web-based services that optimize clinical trial performance, received a 2014 Global Award for its art and technique: animation entry, “Firecrest Through the Body.” This 3D animated video was created and developed by a team of 3D graphic designers and pharmacologists at Firecrest.

More... »

Quest Diagnostics

PPD’s Randy Anderson named Health Care Hero for diabetes research

Thursday, November 20, 2014 12:49 PM

Randy Anderson, Ph.D., vice president of global product development and therapeutic area leader for metabolics at global CRO Pharmaceutical Product Development (PPD), was named a 2014 Health Care Hero. The annual awards honor members of the greater Wilmington medical community for their engagement on critical health issues.

More... »


Vermillion forms new strategic and medical advisory board

Thursday, November 20, 2014 12:43 PM

Vermillion, a bio-analytical solutions company focused on gynecologic disease, recently outlined its expanded strategy for driving improvements in the personalized management of gynecologic health and becoming a leading diagnostic innovator in gynecologic informatics. In support of this mission, the company has named three charter members of its strategic and medical advisory board.

More... »

Edward Lanphier elected chairman of the Alliance for Regenerative Medicine

Thursday, November 13, 2014 02:15 PM

Sangamo BioSciences has announced that Edward Lanphier, the company's president and CEO, has been elected as the next chairman of the Alliance for Regenerative Medicine (ARM). Wash. D.C.-based ARM is an international organization that represents and supports industry, clinical institutions, patient advocates and other stakeholders in the development of safe and effective gene and cell therapies. Lanphier succeeds Geoff MacKay, president and CEO of Organogenesis, who will complete his two-year term as chairman on Dec. 31.

More... »

inVentiv Health names Jeffrey Wilks president of advertising

Thursday, November 13, 2014 02:10 PM

inVentiv Health, a life science knowledge and services company for the new healthcare environment, has appointed of Jeffrey Wilks as president of its advertising businesses. Wilks will report to Mike Griffith, executive vice president, inVentiv Health and president, inVentiv Commercial.

More... »

Greenphire Joins the Deloitte 2014 Technology Fast 500

Thursday, November 13, 2014 01:49 PM

Greenphire, a provider of payment technology for the clinical trials industry, has won a place in Deloitte's 2014 Technology Fast 500. Ranking 48th in the annual list of the fastest growing technology companies in the U.S, Greenphire secured its place as a result of an exceptional 2782% growth over the past four years.

More... »

Stephen T. Sonis joins PlasmaTech Biopharmaceuticals' scientific advisory board

Friday, November 7, 2014 02:07 PM

PlasmaTech Biopharmaceuticals, a biopharmaceutical company advancing patient care in critical areas, has announced that Stephen T. Sonis, DMD, DMSc, has joined its scientific advisory board (SAB). A world-renowned expert in the clinical treatment and research of cancer-related mucosal toxicities, Sonis has collaborated with management in recent years on advancing the company's clinical efforts of its oral mucositis treatment, MuGard.

More... »

Cloud Pharmaceuticals ratifies board of directors

Friday, November 7, 2014 01:42 PM

Cloud Pharmaceuticals, a therapeutics company focused on cloud-based drug design and development, has ratified its board of directors. Members of the board include Cloud Pharmaceuticals chairman and CEO Ed Addison, chief scientific officer Shahar Keinan, Ph.D., and chief information officer Lawrence Husick. Other members of the board include:

More... »

Lexicon expands management

Thursday, November 6, 2014 03:13 PM

Lexicon Pharmaceuticals has announced management additions directed toward the completion of phase III development and commercial preparations for telotristat etiprate in carcinoid syndrome and preparation for phase III initiation and commercial readiness for sotagliflozin (LX4211) in type 1 diabetes.

More... »

CluePoints wins ENTENTE Life Science Investment Forum Award

Thursday, October 30, 2014 01:32 PM

CluePoints, a provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials, has secured an ENTENTE Life Science Investment Forum Award. The award program, which is organized by the ENTENTE project and supported by the European Commission and EuropaBio, recognized CluePoints as one of Belgium's most innovative high technology businesses for its Central Statistical Monitoring (CSM) solution, which employs unique statistical algorithms to determine the quality, accuracy and integrity of clinical trial data.

More... »

AiCure
CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs